Annema W, Gawinecka J, Muendlein A, Saely C, Drexel H, von Eckardstein A. Elevated levels of apolipoprotein D predict poor outcome in patients with suspected or established coronary artery disease. Atherosclerosis. 2022;341:27-33 pubmed publisher

Kuiperij H, Hondius D, Kersten I, Versleijen A, Rozemuller A, Greenberg S, et al. Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy. Neuropathol Appl Neurobiol. 2019;: pubmed publisher

Herzig K, Leppäluoto J, Jokelainen J, Meugnier E, Pesenti S, Selänne H, et al. Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes. Sci Rep. 2017;7:11267 pubmed publisher

Braesch Andersen S, Beckman L, Paulie S, Kumagai Braesch M. ApoD mediates binding of HDL to LDL and to growing T24 carcinoma. PLoS ONE. 2014;9:e115180 pubmed publisher